{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:33:16Z","timestamp":1792481596612,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Various neurological manifestations of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported, associated with a broad spectrum of diverse neurological symptoms and syndromes. Estimating rate and relevance of these manifestations remains difficult as there is a lack of standardised case definitions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We defined comprehensive categories including most reported neurological manifestations associated with SARS-CoV-2 to allow for a more standardised data collection. After a literature search of MEDLINE with ten keywords, 12 selected studies and larger case series were included. We compared the rate and relevance of neurological manifestations in hospitalized patients. We propose four main categories including 1) cerebrovascular disease, 2) inflammatory syndromes of the central nervous system (CNS), peripheral nervous system (PNS) and muscle, 3) metabolic\/toxic dysfunction of CNS, PNS and muscle and 4) miscellaneous disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Ageusia (702) and anosmia (805) have been reported as the most common and the first occurring neurological symptoms. Cerebrovascular disease (451) and encephalopathy (663) were associated with a more severe course and worse clinical outcome. Any neurological manifestation was associated with a longer hospital stay and a higher morbidity and mortality compared to patients without neurological manifestations. We suggest reporting future neurological manifestations of coronavirus disease-19 (COVID-19) following a pathophysiology-based approach using standardized pre-defined case definitions to yield more specific and comparable data.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-021-00138-9","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T04:02:56Z","timestamp":1627272176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Neurological manifestations of COVID-19 \u2013 an approach to categories of pathology"],"prefix":"10.1186","volume":"3","author":[{"given":"Yana","family":"Leven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-0473","authenticated-orcid":false,"given":"Julian","family":"B\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"issue":"3","key":"138_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11910-021-01102-5","volume":"21","author":"S Andalib","year":"2021","unstructured":"Andalib, S., Biller, J., Di Napoli, M., Moghimi, N., McCullough, L. D., Rubinos, C. A., \u2026 Divani, A. A. (2021). Peripheral nervous system manifestations associated with COVID-19. Current Neurology and Neuroscience Reports, 21(3), 9. https:\/\/doi.org\/10.1007\/s11910-021-01102-5.","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"138_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"Association, A. P","year":"2013","unstructured":"Association, A. P (2013). Diagnostic and statistical manual of mental disorders. https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"issue":"9","key":"138_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., \u2026 Solomon, T. (2020). Neurological associations of COVID-19. Lancet Neurology, 19(9), 767\u2013783. https:\/\/doi.org\/10.1016\/S1474-4422(20)30221-0.","journal-title":"Lancet Neurology"},{"key":"138_CR4","doi-asserted-by":"publisher","unstructured":"Ermis, U., Rust, M. I., Bungenberg, J. et al (2021). Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.. Neurol Res Pract, 3(17), 10. https:\/\/doi.org\/10.1186\/s42466-021-00116-1.","DOI":"10.1186\/s42466-021-00116-1"},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fneur.2020.00806","volume":"11","author":"S Fan","year":"2020","unstructured":"Fan, S., Xiao, M., Han, F., Xia, P., Bai, X., Chen, H., \u2026 Guan, H. (2020). Neurological manifestations in critically ill patients With COVID-19: A retrospective study. Frontiers in Neurology, 11, 806. https:\/\/doi.org\/10.3389\/fneur.2020.00806.","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"138_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","volume":"76","author":"M Fotuhi","year":"2020","unstructured":"Fotuhi, M., Mian, A., Meysami, S., & Raji, C. A. (2020). Neurobiology of COVID-19. Journal of Alzheimer's Disease, 76(1), 3\u201319. https:\/\/doi.org\/10.3233\/JAD-200581.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1","key":"138_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12028-020-00995-3","volume":"33","author":"J Frontera","year":"2020","unstructured":"Frontera, J., Mainali, S., Fink, E. L., Robertson, C. L., Schober, M., Ziai, W., \u2026 Study, G.-N (2020a). Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study design and rationale. Neurocritical Care, 33(1), 25\u201334. https:\/\/doi.org\/10.1007\/s12028-020-00995-3.","journal-title":"Neurocritical Care"},{"issue":"4","key":"138_CR8","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1212\/WNL.0000000000010979","volume":"96","author":"JA Frontera","year":"2020","unstructured":"Frontera, J. A., Sabadia, S., Lalchan, R., Fang, T., Flusty, B., Millar-Vernetti, P., \u2026 Galetta, S. (2020b). A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York City. Neurology., 96(4), e575\u2013e586. https:\/\/doi.org\/10.1212\/WNL.0000000000010979.","journal-title":"Neurology."},{"key":"138_CR9","volume-title":"Clinical methods: the history, physical and laboratory examinations","author":"DC Good","year":"1990","unstructured":"Good, D. C. (1990). Chapter 55 cerebrovascular disease. In Butterworths (Ed.), Clinical methods: the history, physical and laboratory examinations, (3rd ed., ).","edition":"3"},{"issue":"4","key":"138_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., \u2026 Dalmau, J. (2016). A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology, 15(4), 391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurology"},{"issue":"23","key":"138_CR11","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., \u2026 Meziani, F. (2020). Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine, 382(23), 2268\u20132270. https:\/\/doi.org\/10.1056\/NEJMc2008597.","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"138_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s15010-020-01499-0","volume":"49","author":"CEM Jakob","year":"2021","unstructured":"Jakob, C. E. M., Borgmann, S., Duygu, F., Behrends, U., Hower, M., Merle, U., \u2026 Vehreschild, J. J. (2021). First results of the \u201clean European open survey on SARS-CoV-2-infected patients (LEOSS)\u201d. Infection, 49(1), 63\u201373. https:\/\/doi.org\/10.1007\/s15010-020-01499-0.","journal-title":"Infection"},{"key":"138_CR13","doi-asserted-by":"publisher","unstructured":"Kim, J. W., Abdullayev, N., Neuneier, J. et al (2021). Post-COVID-19 encephalomyelitis. Neurological Research and Practice, 3(18), 2.https:\/\/doi.org\/10.1186\/s42466-021-00113-4.","DOI":"10.1186\/s42466-021-00113-4"},{"key":"138_CR14","doi-asserted-by":"publisher","first-page":"117118","DOI":"10.1016\/j.jns.2020.117118","volume":"418","author":"JS Koh","year":"2020","unstructured":"Koh, J. S., De Silva, D. A., Quek, A. M. L., Chiew, H. J., Tu, T. M., Seet, C. Y. H., \u2026 Umapathi, T. (2020). Neurology of COVID-19 in Singapore. Journal of the Neurological Sciences, 418, 117118. https:\/\/doi.org\/10.1016\/j.jns.2020.117118.","journal-title":"Journal of the Neurological Sciences"},{"issue":"11","key":"138_CR15","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/acn3.51210","volume":"7","author":"EM Liotta","year":"2020","unstructured":"Liotta, E. M., Batra, A., Clark, J. R., Shlobin, N. A., Hoffman, S. C., Orban, Z. S., & Koralnik, I. J. (2020). Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Annals of Clinical Translational Neurology, 7(11), 2221\u20132230. https:\/\/doi.org\/10.1002\/acn3.51210.","journal-title":"Annals of Clinical Translational Neurology"},{"key":"138_CR16","volume-title":"Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China","author":"L Mao","year":"2020","unstructured":"Mao, L., Jin, H., Wang, M., Hu Y, Chen S, He Q, \u2026, Miao X.(2020). Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan China"},{"issue":"11","key":"138_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke, J., L\u00fctgehetmann, M., Hagel, C., Sperhake, J. P., Schr\u00f6der, A. S., Edler, C., \u2026 Glatzel, M. (2020). Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurology, 19(11), 919\u2013929. https:\/\/doi.org\/10.1016\/S1474-4422(20)30308-2.","journal-title":"Lancet Neurology"},{"issue":"6","key":"138_CR18","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020). The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmunity Reviews, 19(6), 102537. https:\/\/doi.org\/10.1016\/j.autrev.2020.102537.","journal-title":"Autoimmunity Reviews"},{"key":"138_CR19","volume-title":"Neurological manifestations associated with Covid-19: a multicentre registry","author":"E Meppiel","year":"2020","unstructured":"Meppiel, E., Pfeiffer-Smadja, N., & Maury, A. (2020). Neurological manifestations associated with Covid-19: a multicentre registry. https:\/\/www.clinicalmicrobiologyandinfection.com\/article\/S1198-743X(20)30698-4\/fulltext"},{"key":"138_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbi.2020.05.002","volume":"87","author":"PP Panciani","year":"2020","unstructured":"Panciani, P. P., Saraceno, G., Zanin, L., Renisi, G., Signorini, L., Battaglia, L., & Fontanella, M. M. (2020). SARS-CoV-2: \u201cthree-steps\u201d infection model and CSF diagnostic implication. Brain, Behavior, and Immunity, 87, 128\u2013129. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.002.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"10","key":"138_CR21","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1093\/brain\/awaa240","volume":"143","author":"RW Paterson","year":"2020","unstructured":"Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., \u2026 Zandi, M. S. (2020). The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain, 143(10), 3104\u20133120. https:\/\/doi.org\/10.1093\/brain\/awaa240.","journal-title":"Brain"},{"key":"138_CR22","doi-asserted-by":"publisher","unstructured":"Porta-Etessam, J., N\u00fa\u00f1ez-Gil, I. J., Gonz\u00e1lez Garc\u00eda, N., Fernandez-Perez, C., Viana-Llamas, M. C., Eid, C. M., \u2026 Estrada, V. (2021). COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection. https:\/\/doi.org\/10.1007\/s15010-021-01587-9.","DOI":"10.1007\/s15010-021-01587-9"},{"key":"138_CR23","doi-asserted-by":"publisher","unstructured":"Rifino, N., Censori, B., Agazzi, E., Alimonti, D., Bonito, V., Camera, G., \u2026 Sessa, M. (2020). Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII hospital, Bergamo, Italy. Journal of Neurology. https:\/\/doi.org\/10.1007\/s00415-020-10251-5.","DOI":"10.1007\/s00415-020-10251-5"},{"issue":"8","key":"138_CR24","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"CM Romero-S\u00e1nchez","year":"2020","unstructured":"Romero-S\u00e1nchez, C. M., D\u00edaz-Maroto, I., Fern\u00e1ndez-D\u00edaz, E., S\u00e1nchez-Larsen, \u00c1., Layos-Romero, A., Garc\u00eda-Garc\u00eda, J., \u2026 Segura, T. (2020). Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology, 95(8), e1060\u2013e1070. https:\/\/doi.org\/10.1212\/WNL.0000000000009937.","journal-title":"Neurology"},{"issue":"24","key":"138_CR25","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0b013e31823dc535","volume":"77","author":"TF Scott","year":"2011","unstructured":"Scott, T. F., Frohman, E. M., De Seze, J., Gronseth, G. S., Weinshenker, B. G., & Neurology, T. a. T. A. S. o. A. A. o (2011). Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology, 77(24), 2128\u20132134. https:\/\/doi.org\/10.1212\/WNL.0b013e31823dc535.","journal-title":"Neurology"},{"issue":"3","key":"138_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s13365-020-00851-2","volume":"26","author":"A Sepehrinezhad","year":"2020","unstructured":"Sepehrinezhad, A., Shahbazi, A., & Negah, S. S. (2020). COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review. Journal of Neurovirology, 26(3), 324\u2013329. https:\/\/doi.org\/10.1007\/s13365-020-00851-2.","journal-title":"Journal of Neurovirology"},{"issue":"5","key":"138_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s00134-019-05907-4","volume":"46","author":"AJC Slooter","year":"2020","unstructured":"Slooter, A. J. C., Otte, W. M., Devlin, J. W., Arora, R. C., Bleck, T. P., Claassen, J., \u2026 Stevens, R. D. (2020). Updated nomenclature of delirium and acute encephalopathy: Statement of ten societies. Intensive Care Medicine, 46(5), 1020\u20131022. https:\/\/doi.org\/10.1007\/s00134-019-05907-4.","journal-title":"Intensive Care Medicine"},{"issue":"4","key":"138_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon, T., Michael, B. D., Smith, P. E., Sanderson, F., Davies, N. W., Hart, I. J., \u2026 Groups, N. E. G. D. a. S. (2012). Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. The Journal of Infection, 64(4), 347\u2013373. https:\/\/doi.org\/10.1016\/j.jinf.2011.11.014.","journal-title":"The Journal of Infection"},{"issue":"3","key":"138_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","volume":"47","author":"AR Tunkel","year":"2008","unstructured":"Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., \u2026 America, I. D. S. o. (2008). The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 47(3), 303\u2013327. https:\/\/doi.org\/10.1086\/589747.","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"138_CR30","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004). Practice guidelines for the management of bacterial meningitis. Clinical Infectious Diseases, 39(9), 1267\u20131284. https:\/\/doi.org\/10.1086\/425368.","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"138_CR31","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel, A. R., Hasbun, R., Bhimraj, A., Byers, K., Kaplan, S. L., Scheld, W. M., \u2026 Zunt, J. R. (2017). 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated Ventriculitis and meningitis. Clinical Infectious Diseases, 64(6), e34\u2013e65. https:\/\/doi.org\/10.1093\/cid\/ciw861.","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"138_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/jnr.24752","volume":"99","author":"VN Uversky","year":"2021","unstructured":"Uversky, V. N., Elrashdy, F., Aljadawi, A., Ali, S. M., Khan, R. H., & Redwan, E. M. (2021). Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? Journal of Neuroscience Research, 99(3), 750\u2013777. https:\/\/doi.org\/10.1002\/jnr.24752.","journal-title":"Journal of Neuroscience Research"},{"issue":"10","key":"138_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"7","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., \u2026 Group, C. S (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry, 7(10), 875\u2013882. https:\/\/doi.org\/10.1016\/S2215-0366(20)30287-X.","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"138_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan, A., Tunkel, A. R., Bloch, K. C., Lauring, A. S., Sejvar, J., Bitnun, A., \u2026 Consortium, I. E. (2013). Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium. Clinical Infectious Diseases, 57(8), 1114\u20131128. https:\/\/doi.org\/10.1093\/cid\/cit458.","journal-title":"Clinical Infectious Diseases"},{"key":"138_CR35","unstructured":"WHO. (2020a). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020"},{"key":"138_CR36","volume-title":"Coronavirus disease 2019 (COVID-19) Situation Report \u2013 61","author":"WHO","year":"2020","unstructured":"WHO. (2020b ). Coronavirus disease 2019 (COVID-19) Situation Report \u2013 61. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331605\/nCoVsitrep21Mar2020-eng.pdf?sequence=1&isAllowed=y"},{"issue":"8","key":"138_CR37","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurology, 77(8), 1018\u20131027. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2065.","journal-title":"JAMA Neurology"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-021-00138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-021-00138-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-021-00138-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T04:03:03Z","timestamp":1627272183000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-021-00138-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1186\/s42466-021-00138-9","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Yana Leven reports no competing interests. Julian B\u00f6sel has received speaker\u2019s honoraria and travel support from Boehringer Ingelheim, Medtronic, and Zoll, participated in a PCORI research award for the SETPOINT2 trial and is one of the PIs of the PANDEMIC registry study on Neurological manifestations of COVID-19 in critically ill patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}